RUA Life Sciences Plc

Market Cap: Micro Cap
Industry: Pharmaceuticals & Biotechnology
ISIN: GB0033360586

GBP

0.14

0 (-1.79%)

Mar 20

LON

View all stocks in this country

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Kromek Group Plc

Cambridge Nutritional Sciences Plc

Surgical Innovations Group Plc

Polarean Imaging Plc

NetScientific Plc

Inspiration Healthcare Group Plc

RUA Life Sciences Plc

MyHealthChecked Plc

Abingdon Health Plc

Proteome Sciences Plc

Genedrive Plc

Why is RUA Life Sciences Plc ?

Flat results in Sep 25

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of 14.29%, its profits have fallen by -37%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is RUA Life Sciences Plc for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

RUA Life Sciences Plc

12.24%

0.69

35.59%

FTSE 100

13.98%

1.15

13.60%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

35.93%

EBIT Growth (5y)

7.84%

EBIT to Interest (avg)

-1.93

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.43

Sales to Capital Employed (avg)

0.37

Tax Ratio

1.10%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

0.00%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

1.16

EV to EBIT

-5.29

EV to EBITDA

-5.29

EV to Capital Employed

1.28

EV to Sales

1.19

PEG Ratio

Dividend Yield

ROCE (Latest)

-20.53%

ROE (Latest)

-2.17%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bearish

Mildly Bullish

RSI

Bullish

Bollinger Bands

Bullish

Mildly Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Bullish

Dow Theory

Bearish

No Trend

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company

RAW MATERIAL COST(Y)

Fallen by -6.49% (YoY

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Here's what is working for RUA Life Sciences Plc

Raw Material Cost

Fallen by -6.49% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales